AbClon Inc.

Research AbClon Inc. (174900.KQ) on Bullrun: market cap KRW 474.86B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker174900.KQ
ExchangeKQ
CountrySouth Korea
SectorHealthcare
IndustryBiotechnology
CurrencyKRW
Market capKRW 474.86B
Financial periodQ2 2026
RevenueKRW 1.68B
Net income-KRW 6.06B
Free cash flow-KRW 6.08B
Gross margin5.2%

Valuation Snapshot

latest market cap is KRW 474.86B.

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	KRW 474.86B	n/a	n/a	n/a

Dividend history

About AbClon Inc.

AbClon Inc. engages in the research and development of antibody drugs in South Korea and Sweden. The company's products in pipeline include NEST platform technology products for breast and gastric cancers; AffiMab platform technology products for colon cancer and autoimmune diseases; and CAR-T platform technology products for hematologic and ovarian cancers. AbClon Inc. was founded in 2010 and is based in Seoul, South Korea.

Related stock research

South Korea stocks South Korea Healthcare stocks A-Z stock index

Other Healthcare stocks

ORIENT BIO Inc. (002630.KS) GC Corp. (005250.KS) Pharmicell Co., Ltd. (005690.KS) Kanaph Therapeutics Inc. (0082N0.KQ) Samik Pharmaceutical Company LTD. (014950.KQ) HLB Co., Ltd. (028300) Mgen Solutions Co., Ltd. (032790.KQ) Daesung Microbiological Labs. Co., Ltd. (036480.KQ) Seoulin Bioscience Co.,Ltd. (038070.KQ) Hyundai Bioscience Co., Ltd. (048410.KQ) iNtRON Biotechnology, Inc. (048530.KQ) Synergy Innovation Co., Ltd. (048870.KQ)

Frequently asked questions

What is AbClon Inc.'s market cap?

AbClon Inc.'s market capitalization is KRW 474.86B.